An interventional study of Epley Maneuver and Semont Maneuver in Stroke, sponsored by Ibadat International University, Islamabad. Recruiting at 1 site in Pakistan. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-21.
Sponsored by Ibadat International University, Islamabad · Not applicable, Interventional, and Treatment
This randomized controlled trial aims to compare the effectiveness of the Epley maneuver and the Semont maneuver in reducing dizziness and improving balance in stroke survivors diagnosed with posterior canal benign paroxysmal positional vertigo (BPPV). Forty participants will be randomly allocated to either intervention or comparator group. Outcomes will be assessed using the Dizziness Handicap Inventory (DHI), Berg Balance Scale (BBS), and Dix-Hallpike test at baseline, 2 weeks, and 4 weeks.
Benign paroxysmal positional vertigo (BPPV) is the most common peripheral vestibular disorder and frequently affects the posterior semicircular canal. Stroke survivors with BPPV often experience dizziness, impaired balance, and an increased risk of falls. The Epley and Semont maneuvers are evidence-based repositioning techniques used to treat posterior canal BPPV. However, evidence comparing these two maneuvers specifically in stroke survivors is limited. This randomized controlled trial will compare their effectiveness in reducing dizziness and improving balance over a 4-week intervention period with follow-up assessments. The findings may help guide physiotherapists in selecting the most effective treatment for this population.
7,441 studies on the registry are indexed under Stroke; 2,012 are open to participants now.
This study's planned enrollment of 40 is below the median of 50 across 5,482 interventional studies indexed under Stroke.
Browse Stroke studies →Ibadat International University, Islamabad is the lead sponsor of 52 studies on the registry; 35 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Epley Maneuver. Participants will receive the Epley repositioning maneuver performed by a trained physiotherapist, 4 repetitions per session, 2-4 sessions per week for 4 weeks.
Other: Epley Maneuver
Semont Maneuver. Participants will receive the Semont repositioning maneuver performed by a trained physiotherapist, 4 repetitions per session, 2-4 sessions per week for 4 weeks.
Other: Semont Maneuver
Epley Maneuver: Participants will be randomly allocated to either the Epley maneuver group or the Semont maneuver group. The affected side will be identified using the Dix-Hallpike test before treatment. Participants in the Epley group will receive the canalith repositioning maneuver involving sequential head and body movements to facilitate the movement of displaced otoconia from the posterior semicircular canal into the utricle.
Participants in the Semont group will receive the liberatory maneuver involving rapid sequential movements between side-lying positions while maintaining the prescribed head rotation.
Dizziness Handicap Inventory
To assess the severity and impact of dizziness and balance in physical aspects of daily life. The questionnaire consists of 25 items scored as 0 (no), 2 (sometimes), and 4 (yes), yielding a total score ranging from 0 to 100. Higher scores indicate greater dizziness-related handicap. Total scores will be interpreted as mild (0-30), moderate (31-60), or severe (61-100) handicap
Time frame: Baseline, 2 weeks, and 4 weeks
Berg Balance Scale
The scale consists of 14 tasks, each scored from 0 to 4, yielding a total score ranging from 0 to 56. Higher scores indicate better balance performance, whereas lower scores indicate greater balance impairment
Time frame: Baseline, 2 weeks, and 4 weeks
Plan to share: No
No publications or documents are linked to this record.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ibadat International University, Islamabad